A Multicentric, Open-Label, Randomized, Comparative Clinical Trial of Two Different Doses of Expanded hBM-MSCs Plus Biomaterial versus Iliac Crest Autograft, for Bone Healing in Nonunions after Long Bone Fractures: Study Protocol

ORTHOUNION is a multicentre, open, comparative, three-arm, randomized clinical trial (EudraCT number 2015-000431-32) to compare the efficacy, at one and two years, of autologous human bone marrow-derived expanded mesenchymal stromal cell (hBM-MSC) treatments versus iliac crest autograft (ICA) to enhance bone healing in patients with diaphyseal and/or metaphysodiaphyseal fracture (femur, tibia, and humerus) status of atrophic or oligotrophic nonunion (more than 9 months after the acute fracture, including recalcitrant cases after failed treatments). The primary objective is to determine if the treatment with hBM-MSCs combined with biomaterial is superior to ICA in obtaining bone healing. If confirmed, a secondary objective is set to determine if the dose of 100 × 106 hBM-MSCs is noninferior to that of 200 × 106 hBM-MSCs. The participants (n = 108) will be randomly assigned to either the experimental low dose (n = 36), the experimental high dose (n = 36), or the comparator arm (n = 36) using a central randomization service. The trial will be conducted in 20 clinical centres in Spain, France, Germany, and Italy under the same clinical protocol. The confirmation of superiority for the proposed ATMP in nonunions may foster the future of bone regenerative medicine in this indication. On the contrary, absence of superiority may underline its limitations in clinical use.

[1]  P. Layrolle,et al.  Enhanced human bone marrow mesenchymal stromal cell adhesion on scaffolds promotes cell survival and bone formation. , 2017, Acta biomaterialia.

[2]  R. Moghadasali,et al.  Mesenchymal Stromal Cells Implantation in Combination with Platelet Lysate Product Is Safe for Reconstruction of Human Long Bone Nonunion , 2016, Cell journal.

[3]  A. Ignatius,et al.  Fracture Healing Is Delayed in Immunodeficient NOD/scid‑IL2Rγcnull Mice , 2016, PloS one.

[4]  A. Kamal,et al.  Autologous mesenchymal stem cell (MSCs) transplantation for critical-sized bone defect following a wide excision of osteofibrous dysplasia , 2015, International journal of surgery case reports.

[5]  P. Bierling,et al.  Bone-Forming Capacity and Biodistribution of Bone Marrow-Derived Stromal Cells Directly Loaded into Scaffolds: A Novel and Easy Approach for Clinical Application of Bone Regeneration , 2015, Cell transplantation.

[6]  K. Tarte,et al.  Effects of a ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin. , 2015, Tissue engineering. Part A.

[7]  P. Layrolle,et al.  Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: the local implication of osteoclasts and macrophages. , 2014, Biomaterials.

[8]  T. Miramond,et al.  Osteoinduction of biphasic calcium phosphate scaffolds in a nude mouse model , 2014, Journal of biomaterials applications.

[9]  E. Gómez-Barrena,et al.  Regulatory authorities and orthopaedic clinical trials on expanded mesenchymal stem cells , 2014, International Orthopaedics.

[10]  P. Hernigou,et al.  Morbidity of graft harvesting versus bone marrow aspiration in cell regenerative therapy , 2014, International Orthopaedics.

[11]  F. Catani,et al.  Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration. , 2014, Tissue engineering. Part C, Methods.

[12]  R. Capanna,et al.  Cost effectiveness of tibial nonunion treatment: A comparison between rhBMP-7 and autologous bone graft in two Italian centres. , 2013, Injury.

[13]  P. Layrolle,et al.  Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate , 2013, Stem Cell Research & Therapy.

[14]  J. Schroeder,et al.  Stem cell-based therapy for prevention of delayed fracture union: a randomized and prospective preliminary study. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  J. Bishop,et al.  Assessment of Compromised Fracture Healing , 2012, The Journal of the American Academy of Orthopaedic Surgeons.

[16]  A. Ignatius,et al.  Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components , 2012, Cytotherapy.

[17]  W. Obremskey,et al.  Bone morphogenetic protein-2 compared to autologous iliac crest bone graft in the treatment of long bone nonunion. , 2011, Orthopedics.

[18]  F. Luyten,et al.  Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology , 2011, Journal of cellular and molecular medicine.

[19]  N. Ashammakhi,et al.  Successful treatment of refractory tibial nonunion using calcium sulphate and bone marrow stromal cell implantation. , 2007, The Journal of bone and joint surgery. British volume.

[20]  Maurilio Marcacci,et al.  Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. , 2007, Tissue engineering.

[21]  T. Miclau,et al.  Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? , 2007, Injury.

[22]  M. Jensen,et al.  Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. , 2003, The journal of pain : official journal of the American Pain Society.

[23]  Emil H Schemitsch,et al.  A Lack of Consensus in the Assessment of Fracture Healing Among Orthopaedic Surgeons , 2002, Journal of orthopaedic trauma.

[24]  G. Zych,et al.  Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.

[25]  M Kieser,et al.  Sample size determination for proving equivalence based on the ratio of two means for normally distributed data. , 1999, Statistics in medicine.

[26]  J. Goulet,et al.  Autogenous Iliac Crest Bone Graft: Complications and Functional Assessment , 1997, Clinical orthopaedics and related research.

[27]  J. Fleiss,et al.  A simple approximation for calculating sample sizes for comparing independent proportions. , 1980, Biometrics.

[28]  Philippe Rosset,et al.  Bone fracture healing: cell therapy in delayed unions and nonunions. , 2015, Bone.

[29]  G. Schmidmaier,et al.  Autograft versus BMPs for the treatment of non-unions: what is the evidence? , 2013, Injury.

[30]  S. Giannotti,et al.  Treatment of pseudoarthrosis of the upper limb using expanded mesenchymal stem cells: a pilot study. , 2013, European review for medical and pharmacological sciences.

[31]  Michael J. Campbell,et al.  Statistical tables for the design of clinical trials , 1987 .

[32]  M. Müller,et al.  Manual of Internal Fixation , 1970, Springer Berlin Heidelberg.